Ved Desai
Hematology & Oncology · Springfield, NJNPI 1871869511
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,494 of the $1,667 with a category attached, or 89.6%. It is spread thinly across 31 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $749 and has fallen 86.5% since, to $101 in 2025. That places this record below the midpoint for hematology & oncology clinicians in NJ, where the typical reported total is $2,686.
Across 105 payments — averaging $15.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$229
- Novartis$213
- AbbVie$120
- E.r. Squibb & Sons, L.L.C.$95
- Johnson & Johnson$91
- Pfizer$79
- plus $841 from 25 others
What the payments were for
- Travel & lodging$1509%
- Food & beverage$1,49490%
- Education$231%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 6 | $229 |
| Novartis | 12 | $213 |
| AbbVie | 8 | $120 |
| E.r. Squibb & Sons, L.L.C. | 7 | $95 |
| Johnson & Johnson(2 entities) | 6 | $91 |
| Pfizer | 6 | $79 |
| Astellas Pharma US Inc | 4 | $58 |
| Amgen | 4 | $55 |
| Gilead(2 entities) | 4 | $55 |
| AstraZeneca(2 entities) | 4 | $55 |
| Regeneron Healthcare Solutions, Inc. | 4 | $54 |
| Sanofi | 4 | $52 |
| Bayer | 3 | $49 |
| Bristol Myers Squibb | 4 | $49 |
| Genentech USA, Inc. | 3 | $46 |
| Rigel Pharmaceuticals, Inc. | 3 | $46 |
| Taiho Oncology, Inc. | 3 | $44 |
| Eisai Inc. | 3 | $43 |
| Incyte Corporation | 3 | $38 |
| Jazz Pharmaceuticals Inc. | 2 | $32 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| Lilly USA, LLC | 1 | $15 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| Blueprint Medicines Corporation | 1 | $14 |
| Servier Pharmaceuticals LLC | 1 | $13 |
| Seagen Inc. | 1 | $13 |
| Novocure Inc. | 1 | $13 |
| Octapharma USA, Inc. | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
| Lexicon Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KEYTRUDA$150
How this compares
$1,667 in reported general payments places this provider in the 40th percentile of 362 hematology & oncology providers in New Jersey.
Other hematology & oncology in Springfield
- Joshua StraussSpringfield$739K
- Ashish ShahSpringfield$394K
- Ashish KhotSpringfield$88K
- Maithili RaoSpringfield$29K
- Robert SpiegelWestfield$864K
- Amit PatelJersey City$770K
- Charles FarberMorristown$609K
- Michael ScolaMorristown$506K
- Eshan PatelSomerville$420K
- Arturo Loaiza-BonillaPennington$406K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.